RN

Ranjana Nathuji Nandanwar

Active Director Director DIN 10479472
DIN 10479472 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ranjana Nathuji Nandanwar

Data last updated:

Ranjana Nathuji Nandanwar is a Director at Elixion Medicare Private Limited (since 2024). The company operates in Pharma.

DIN 10479472
Primary Designation Director
Industry Pharma
First Appointment 04 Sep 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elixion Medicare Private Limited U24230MH2022PTC396378
Director04 Sep 20242022Active

Board colleagues of Ranjana Nathuji Nandanwar

NameDINCompanyDesignation
Mayur Shivshankar Hedaoo10764022Elixion Medicare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Elixion Medicare Private Limited
Premium access

Shareholding and investment profile for Ranjana Nathuji Nandanwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjana Nathuji Nandanwar

Ranjana Nathuji Nandanwar currently holds 1 directorship: Elixion Medicare Private Limited (Director, since 04 Sep 2024).

Ranjana Nathuji Nandanwar was first appointed on 04 Sep 2024 as Director at Elixion Medicare Private Limited.

The current boards of Ranjana Nathuji Nandanwar's companies include Mayur Shivshankar Hedaoo (Elixion Medicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available